Blog: BIOSIG TECHNOLOGIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure.

On May 10, 2022, BioSig Technologies, Inc. (the “Company”) issued a letter to
shareholders, which is attached hereto as Exhibit 99.1, providing highlights on
the Company’s recent developments and updates. The Company undertakes no
obligation to update, supplement or amend the materials attached hereto as
Exhibits 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this
Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not
be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Exchange Act or the Securities Act of 1933, as amended,
except as shall be expressly set forth by reference in such a filing.
Furthermore, the furnishing of information under Item 7.01 of this Current
Report on Form 8-K is not intended to constitute a determination by the Company
that the information contained herein, including the exhibits hereto, is
material or that the dissemination of such information is required by Regulation

Item 9.01       Financial Statements and Exhibits.

(d) Exhibits

Number    Description
99.1        Shareholder
          Letter, dated May
          2022 (furnished
          herewith pursuant
          to Item 7.01)
104       Cover Page
          Interactive Data
          File (formatted
          as Inline XBRL)


© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s